ORGANIC
LETTERS
2004
Vol. 6, No. 24
4535-4538
Stereoselective Total Synthesis of
ent-EI-1941-2 and Epi-ent-EI-1941-2
Mitsuru Shoji, Takao Uno, and Yujiro Hayashi*
Department of Industrial Chemistry, Faculty of Engineering, Tokyo UniVersity of
Science, Kagurazaka, Shinjuku-ku, Tokyo 162-8601, Japan
Received September 14, 2004
ABSTRACT
The first asymmetric total syntheses of ent-EI-1941-2 and epi-ent-EI-1941-2 have been accomplished, starting from a chiral epoxy iodoquinone
6, a key intermediate in our total syntheses of epoxyquinols A and B. A key step in the preparation of ent-EI-1941-2 is an intramolecular
carboxypalladation via a 6-endo cyclization mode, followed by
of epi-ent-EI-1941-2.
â
-hydride elimination, while carboxymercuration is a key step in the synthesis
Interleukin-1â (IL-1â) converting enzyme (ICE) is a cysteine
protease that cleaves a biologically inactive 31 KDa precursor
to biologically active IL-1â,1 an important mediator in the
pathogenesis of rheumatoid arthritis, septic shock, inflam-
mation, and other physiological conditions.2 Therefore, it is
thought that ICE inhibitors would be useful as antiinflam-
matory drugs. Koizumi and co-workers have isolated EI-
1941-1 (1), EI-1941-2 (2), and EI-1941-3 (3) from culture
broths of Farrowia sp., the first two of which selectively
inhibit human recombinant ICE activity with IC50 values of
0.086 and 0.006 µM, respectively.3 Just recently, the relative
and absolute stereochemistries of EI-1941-1 and -2 have been
determined by X-ray crystallographic analysis of the p-
bromobenzoyl ester of EI-1941-2.4
Structurally, EI-1941-1 and EI-1941-2 (Figure 1) have an
epoxyquinone core, and due to our interest in the synthesis
of such epoxyquinone derivatives, including ECH5 and its
dimers, epoxyquinols A and B,6 we set out to accomplish
the first asymmetric total synthesis of ent-EI-1941-2, the
achievement of which will be disclosed in this paper.
A retrosynthetic analysis of EI-1941-2 is depicted in
Scheme 1. At the time that we started this project, their
(4) Koizumi, F.; Takahashi, Y.; Ishiguro, H.; Tanaka, R.; Ohtaki, S.;
Yoshida, M.; Nakanishi, S.; Ikeda, S. Tetrahedron Lett. 2004, 45, 7419.
(5) Kakeya, H.; Miyake, Y.; Shoji, M.; Kishida, S.; Hayashi, Y.; Kataoka,
T.; Osada, H. Bioorg. Med. Chem. Lett. 2003, 13, 3743.
(1) (a) Thornberry, N. A.; Bull, H. G.; Calaycay, J. R.; Chapman, K. T.;
Howard, A. D.; Kostura, M. J.; Miller, D. K.; Molineaux, S. M.; Weidner,
J. R.; Aunins, J.; Elliston, K. O.; Ayala, J. M.; Casano, F. J.; Chin, J.;
Ding, G. J.-F.; Egger, L. A.; Gaffney, E. P.; Limjuco, G.; Palyha, O. C.;
Raju, S. M.; Roland, A, M.; Salley, J. P.; Yamin, T.-T.; Lee, J. A.; Shively,
J. E.; Maccross, M.; Mumford, R. A.; Schmidt, J. A.; Tocci, M. J. Nature
1992, 356, 768. (b) Gerretti, D. P.; Kozlosky, C. J.; Mosley, B.; Nelson,
N.; Ness, K. V.; Greenstreet, T. A.; March, C. J.; Kronheim, S. R.; Druck,
T.; Cannizzaro, L. A.; Huebner, K.; Black, R. A. Science 1992, 256, 97.
(2) (a) Dinarello, C. A. Blood 1991, 77, 1627. (b) Dinarello, C. A.; Wolff.
S. M. N. Engl. J. Med. 1993, 328, 106.
(6) Isolation: (a) Kakeya, H.; Onose, R.; Koshino, H.; Yoshida, A.;
Kobayashi, K.; Kageyama, S.-I.; Osada, H. J. Am. Chem. Soc. 2002, 124,
3496. (b) Kakeya, H.; Onose, R.; Yoshida, A.; Koshino, H.; Osada, H. J.
Antibiot. 2002, 55, 829. Total syntheses: (c) Shoji, M.; Yamaguchi, J.;
Kakeya, H.; Osada, H.; Hayashi, Y. Angew. Chem., Int. Ed. 2002, 41, 3192.
(d) Shoji, M.; Kishida, S.; Takeda, M.; Kakeya, H.; Osada, H.; Hayashi,
Y. Tetrahedron Lett. 2002, 43, 9155. (e) Shoji, M.; Kishida, S.; Kodera,
Y.; Shiina, I.; Kakeya, H.; Osada, H.; Hayashi, Y. Tetrahedron Lett. 2003,
44, 7205. (f) Shoji, M.; Imai, H.; Shiina, I.; Kakeya, H.; Osada, H.; Hayashi,
Y. J. Org. Chem. 2004, 69, 1548. (g) Li, C.; Bardhan, S.; Pace, E. A.;
Liang, M.-C.; Gilmore, T. D.; Porco, J. A., Jr. Org. Lett. 2002, 4, 3267. (h)
Mehta, G.; Islam, K. Tetrahedron Lett. 2003, 44, 3569. (i) Mehta, G.; Islam,
K. Tetrahedron Lett. 2004, 45, 3611.
(3) (a) Koizumi, F.; Matsuda, Y.; Nakanishi, S. J. Antibiot. 2003, 56,
464. (b) Koizumi, F.; Ishiguro, H.; Ando, K.; Kondo, H.; Yoshida, M.;
Matsuda, Y.; Nakanishi, S. J. Antibiot. 2003, 56, 603.
10.1021/ol0481479 CCC: $27.50
© 2004 American Chemical Society
Published on Web 10/23/2004